Skip to main content
Atrás
Watch Compare

NextCure, Inc.

Calidad de datos: 83%
NXTC
NASDAQ Manufacturing Chemicals
$12.77
▲ $0.45 (3.65%)
6 months return
—
Momentum
Neutral
ROE
-209.58%

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-209.58%
Below sector avg (-54.49%)
ROIC-138.93%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio2.97
Interest CoverageN/A

Valoración

PE (TTM|NTM)
-0.73 | -1.84
Above sector avg (-1.50)
P/B Ratio1.73
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -50.09 M

Price History

Tendencias Financieras

Precio Objetivo de Analistas

3 analistas
Buy
+38.3%
upside to target
Actual
$12.77
Consensus Target
$17.67
$15.00
Mín
$20.00
Máx
Pronóstico
P/E Futuro
-1.84
EPS Futuro
-$6.31
Ingresos Est.
0.0

Sorpresas de Ganancias

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -$1.81 · Rev Est: 0.0
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -$4.68 -$11.29 -$3.22 -$0.81 — —
Estimate -$4.80 -$4.62 -$3.98 -$2.29 -$1.81 -$2.00
Sorpresa +2.50% -144.64% +19.16% +64.63% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -209.58% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -55.84 M
ROE -209.58% ROA -127.93%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -50.09 M
ROIC -138.93% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 2.97
Debt / Equity N/A Current Ratio 2.97
Interest Coverage N/A Asset Turnover N/A
Working Capital 21.65 M Tangible Book Value 23.65 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0.73 · EV/EBITDA: N/A
P/E Ratio -0.73 Forward P/E -1.84
P/B Ratio 1.73 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -122.59%
Market Cap 40.86 M Enterprise Value 33.53 M

Per Share

EPS: -19.65 · FCF/Share: -14.07
EPS (Diluted TTM) -19.65 Revenue / Share N/A
FCF / Share -14.07 OCF / Share -13.93
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 89.69% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 89.69%
SBC-Adj. FCF -54.17 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — 22.38 M
Net Income -55.84 M -55.65 M -62.72 M -74.73 M -69.39 M
EPS (Diluted) -19.65 -1.99 -2.25 -2.69 -2.51
Gross Profit — — — — —
Operating Income -57.62 M -59.75 M -67.64 M -75.91 M -70.77 M
EBITDA — — — — —
R&D Expenses 44.92 M 41.49 M 47.93 M 54.20 M 50.19 M
SG&A Expenses — — — — —
D&A 2.20 M 2.90 M 3.70 M 4.10 M 4.30 M
Interest Expense — — — — —
Income Tax 0.0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 50.18 M 80.86 M 128.04 M 184.16 M 242.39 M
Total Liabilities 15.24 M 15.39 M 13.62 M 16.63 M 9.00 M
Shareholders' Equity 34.94 M 65.47 M 114.42 M 167.53 M 233.39 M
Total Debt — — — 0.0 0.0
Cash & Equivalents 25.98 M 27.73 M 13.08 M 26.63 M 12.34 M
Current Assets 43.75 M 71.81 M 112.73 M 163.98 M 227.82 M
Current Liabilities 10.57 M 9.57 M 6.88 M 9.13 M 6.61 M

Comparación con Pares

vs mediana del sector Manufacturing (1605 pares)
Métrica Acción Mediana del Sector
P/E -0.7 -1.5
P/B 1.7 1.6
ROE % -209.6 -54.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

ETFs Holding This Stock
DLHAX DLHAX
0.03% weight
DLRHX DLRHX
0.03% weight
DLHIX DLHIX
0.03% weight
BRSIX BRSIX
0.02% weight